Cargando…

Tyrphostin AG1296, a platelet-derived growth factor receptor inhibitor, induces apoptosis, and reduces viability and migration of PLX4032-resistant melanoma cells

Melanoma is the deadliest form of skin cancer, and BRAFV600E is a driver mutation that promotes melanoma growth and survival. PLX4032 is the first effective compound in clinical use for the treatment of patients with mutant BRAFV600. However, resistance to PLX4032 develops quickly within months. Act...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yanling, Li, Yuping, Liu, Qiang, Wang, Aixue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437616/ https://www.ncbi.nlm.nih.gov/pubmed/25999739 http://dx.doi.org/10.2147/OTT.S70691

Ejemplares similares

Tyrphostin AG 1296 induces glioblastoma cell apoptosis in vitro and in vivo
por: LI, HONGWEI, et al.
Publicado: (2015)

Cytostatic and cytotoxic effects of tyrphostin AG1296 on RMS cells
por: Lasota, Małgorzata, et al.
Publicado: (2012)

Vitamin C sensitizes BRAF(V600E) thyroid cancer to PLX4032 via inhibiting the feedback activation of MAPK/ERK signal by PLX4032
por: Su, Xi, et al.
Publicado: (2021)

PLX4032 Mediated Melanoma Associated Antigen Potentiation in Patient Derived Primary Melanoma Cells
por: George, Andrea L., et al.
Publicado: (2015)

PLX4032 resistance of patient-derived melanoma cells: crucial role of oxidative metabolism
por: Garbarino, Ombretta, et al.
Publicado: (2023)

Additive effect by combination of Akt inhibitor, MK-2206, and PDGFR inhibitor, tyrphostin AG 1296, in suppressing anaplastic thyroid carcinoma cell viability and motility
por: Che, Huan-yong, et al.
Publicado: (2014)

Identification of PLX4032-resistance mechanisms and implications for novel RAF inhibitors
por: Choi, Jaehyuk, et al.
Publicado: (2014)

Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutations
por: Niehr, Franziska, et al.
Publicado: (2011)

The BRAF(V600E) inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells
por: Jenkins, Molly H., et al.
Publicado: (2015)

Differential sensitivity of melanoma cell lines with BRAF(V600E )mutation to the specific Raf inhibitor PLX4032
por: Søndergaard, Jonas N, et al.
Publicado: (2010)

Galectin-3 sensitized melanoma cell lines to vemurafenib (PLX4032) induced cell death through prevention of autophagy
por: Bustos, Silvina Odete, et al.
Publicado: (2018)

Association between acquired resistance to PLX4032 (vemurafenib) and ATP-binding cassette transporter expression
por: Michaelis, Martin, et al.
Publicado: (2014)

Adaptive up-regulation of FOXD3 and resistance to PLX4032/4720-induced cell death in mutant B-RAF melanoma cells
por: Basile, Kevin J., et al.
Publicado: (2011)

Induced cross-resistance of BRAF(V600E) melanoma cells to standard chemotherapeutic dacarbazine after chronic PLX4032 treatment
por: Erdmann, Sarah, et al.
Publicado: (2019)

PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF(WT) melanoma cells
por: Halaban, Ruth, et al.
Publicado: (2010)

Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032
por: Rubinstein, Jill C, et al.
Publicado: (2010)

HO-1 Limits the Efficacy of Vemurafenib/PLX4032 in BRAF(V600E) Mutated Melanoma Cells Adapted to Physiological Normoxia or Hypoxia
por: Furfaro, Anna Lisa, et al.
Publicado: (2022)

Inhibition of zymosan-induced kidney dysfunction by tyrphostin AG-490
por: Dimitrova, Petya, et al.
Publicado: (2009)

Tyrphostin AG17 inhibits adipocyte differentiation in vivo and in vitro
por: Camacho, Alberto, et al.
Publicado: (2018)

Berberine Inhibits Human Melanoma A375.S2 Cell Migration and Invasion via Affecting the FAK, uPA, and NF-κB Signaling Pathways and Inhibits PLX4032 Resistant A375.S2 Cell Migration In Vitro
por: Liu, Jia-Fang, et al.
Publicado: (2018)

Tyrphostin AG 1024 modulates radiosensitivity in human breast cancer cells
por: Wen, B, et al.
Publicado: (2001)

Tyrphostin AG490 reduces inflammation and fibrosis in neonatal obstructive nephropathy
por: Gasparitsch, Mojca, et al.
Publicado: (2019)

The Tyrphostin Agent AG490 Prevents and Reverses Type 1 Diabetes in NOD Mice
por: Davoodi-Semiromi, Abdoreza, et al.
Publicado: (2012)

BML-265 and Tyrphostin AG1478 Disperse the Golgi Apparatus and Abolish Protein Transport in Human Cells
por: Boncompain, Gaelle, et al.
Publicado: (2019)

Synergistic inhibition of MEK/ERK and BRAF V600E with PD98059 and PLX4032 induces sodium/iodide symporter (NIS) expression and radioiodine uptake in BRAF mutated papillary thyroid cancer cells
por: Zhang, Honglai, et al.
Publicado: (2018)

MicroRNA-1296 Facilitates Proliferation, Migration And Invasion Of Colorectal Cancer Cells By Targeting SFPQ
por: Tao, Youmao, et al.
Publicado: (2018)

A cell-based high-throughput screen identifies tyrphostin AG 879 as an inhibitor of animal cell phospholipid and fatty acid biosynthesis
por: Zoeller, Raphael A., et al.
Publicado: (2019)

The inhibition of EGF-dependent proliferation of keratinocytes by tyrphostin tyrosine kinase blockers
Publicado: (1991)

Development and validation of an LC-MS/MS method for tyrphostin A9
por: Meyer, Lyndsey F., et al.
Publicado: (2019)

Tyrphostin AG556 increases the activity of large conductance Ca(2+)‐activated K(+) channels by inhibiting epidermal growth factor receptor tyrosine kinase
por: Wang, Yan, et al.
Publicado: (2017)

Development of Tyrphostin Analogues to Study Inhibition of the Mycobacterium tuberculosis Pup Proteasome System
por: Janssen, Guido V., et al.
Publicado: (2021)

1296. Should HIV Disclosure at ED Based on Preliminary Results?
por: Aguilera, Elizabeth A, et al.
Publicado: (2019)

miR 1296-5p Inhibits the Migration and Invasion of Gastric Cancer Cells by Repressing ERBB2 Expression
por: Shan, Xia, et al.
Publicado: (2017)

Tyrphostins reduce chemotherapy-induced intestinal injury in mice: assessment by a biochemical assay
por: Zlotnik, Y, et al.
Publicado: (2005)

Inhibition of pancreatic cancer cell growth in vitro by the tyrphostin group of tyrosine kinase inhibitors.
por: Gillespie, J., et al.
Publicado: (1993)

In vivo pharmacology and anti-tumour evaluation of the tyrphostin tyrosine kinase inhibitor RG13022.
por: McLeod, H. L., et al.
Publicado: (1996)

Antiproliferative Imidazo-Pyrazole-Based Hydrogel: A Promising Approach for the Development of New Treatments for PLX-Resistant Melanoma
por: Alfei, Silvana, et al.
Publicado: (2023)

Complete Genome Sequence of the Clostridium difficile Type Strain DSM 1296(T)
por: Riedel, Thomas, et al.
Publicado: (2015)

Acute stimulation of glycolytic flux in cultured primary astrocytes by the tyrosine kinase inhibitor tyrphostin 23
por: Blumrich, Eva-Maria, et al.
Publicado: (2015)

Tumor suppressor role of microRNA-1296 in triple-negative breast cancer
por: Phan, Binh, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_oinhu71m9vm8vu3odgbu4n006e